THORLNC and neoplasm: A significant difference was also found in patients 8 (Fig. 3D) and 10 (Fig. 3F) (P = 0.0455 and P = 0.0079, respectively) with lower THOR methylation levels in tumor cells (15% and 22.9%, respectively, for tumor cells; and 6.5% and 11.5%, respectively, for normal cell).